73 related articles for article (PubMed ID: 2032250)
1. Alveolar macrophage and blood monocyte function in lung cancer.
Hosker HS; Corris PA
Cancer Detect Prev; 1991; 15(2):103-6. PubMed ID: 2032250
[TBL] [Abstract][Full Text] [Related]
2. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
Thomassen MJ; Wiedemann HP; Barna BP; Farmer M; Ahmad M
Cancer Res; 1988 Jul; 48(14):3949-53. PubMed ID: 2838166
[TBL] [Abstract][Full Text] [Related]
3. [Chemiluminescent measurements of alveolar macrophages in sarcoidosis patients].
Winsel K; Christ R; Eckert H; Renner H; Unger U; Grollmuss H
Z Erkr Atmungsorgane; 1987; 169(1):23-32. PubMed ID: 3673126
[TBL] [Abstract][Full Text] [Related]
4. Human macrophage function in cancer: systemic and local changes detected by an assay for Fc receptor expression.
Rhodes J; Plowman P; Bishop M; Lipscomb D
J Natl Cancer Inst; 1981 Mar; 66(3):423-9. PubMed ID: 6937700
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cellular cytotoxicity in blood monocytes and alveolar macrophages in patients with lung cancer.
McLennan G; Gill PG; De Young NJ
J Natl Cancer Inst; 1985 Jul; 75(1):23-7. PubMed ID: 3859693
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
Hancock WW; Muller WA; Cotran RS
J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
[TBL] [Abstract][Full Text] [Related]
8. Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes.
Halme M; Maasilta P; Repo H; Ristola M; Taskinen E; Mattson K; Cantell K
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):93-101. PubMed ID: 7995773
[TBL] [Abstract][Full Text] [Related]
9. Role of antitumor activity of alveolar macrophages in lung cancer patients.
Kuda T; Yasumoto K; Yano T; Nakahashi H; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2199-202. PubMed ID: 3829005
[TBL] [Abstract][Full Text] [Related]
10. Effect of IFN-gamma stimulation on expression of intercellular adhesion molecule-1 (ICAM-1) on alveolar macrophages in patients with non-small cell lung cancer.
Dabrowska M; Grubek-Jaworska H; Hoser G; Domagała-Kulawik J; Krenke R; Chazan R
J Interferon Cytokine Res; 2006 Mar; 26(3):190-5. PubMed ID: 16542141
[TBL] [Abstract][Full Text] [Related]
11. Antigenic specificity of human alveolar macrophages and blood monocytes studied by an immunofluorescence technique.
Nakstad B; Lyberg T; Baklien K; Boye NP
J Pathol; 1989 Feb; 157(2):99-107. PubMed ID: 2466114
[TBL] [Abstract][Full Text] [Related]
12. Suppressor cell activity of human alveolar macrophages in interstitial lung diseases.
Fireman EM; Ben Efraim S; Greif J; Kivity S; Topilsky MR
Clin Exp Immunol; 1988 Jul; 73(1):111-6. PubMed ID: 2971484
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes.
Halme M; Maasilta P; Repo H; Leirisalo-Repo M; Taskinen E; Mattson K; Cantell K
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):283-91. PubMed ID: 8061901
[TBL] [Abstract][Full Text] [Related]
14. [Chemiluminescence of alveolar macrophages in pneumonia].
Dohmen BM; Loos U
Pneumologie; 1990 Feb; 44 Suppl 1():467-8. PubMed ID: 2367436
[TBL] [Abstract][Full Text] [Related]
15. [A preliminary study on the role of interleukin-1 in chronic lung disease].
Liu CT; Wang ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):221-3, 255. PubMed ID: 2090352
[TBL] [Abstract][Full Text] [Related]
16. [Oxygen radical production by alveolar macrophages in sarcoidosis in relation to activity status of bronchoalveolar lavage lymphocytes].
Strausz J; Müller-Quernheim J; Steppling H; Nagel M; Ferlinz R
Pneumologie; 1990 Feb; 44 Suppl 1():222-3. PubMed ID: 2367371
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis induction of chemiluminescence and chemoattractant increased superoxide anion release from activated human alveolar macrophages in asthma.
Damon M; Cluzel M; Chanez P; Godard P
J Biolumin Chemilumin; 1989 Jul; 4(1):279-86. PubMed ID: 2552756
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lymphokine-activated killer cell function by human alveolar macrophages.
Roth MD; Golub SH
Cancer Res; 1989 Sep; 49(17):4690-5. PubMed ID: 2788029
[TBL] [Abstract][Full Text] [Related]
19. [Determination of macrophage activity in bronchoalveolar lavage fluid in patients with lung diseases].
Ochendalski M; Müller S; Unger U; Grollmuss H; Schilling W
Z Erkr Atmungsorgane; 1987; 168(1):19-24. PubMed ID: 3577241
[TBL] [Abstract][Full Text] [Related]
20. [Realistic in vitro study of oxygen radical liberation by alveolar macrophages and mononuclear cells of the peripheral blood after short-term exposure to SO2].
Kienast K; Müller-Quernheim J; Knorst M; Schlegel J; Mang C; Ferlinz R
Pneumologie; 1993 Feb; 47(2):60-5. PubMed ID: 8385334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
